Abstract:Chronic hepatitis B virus (HBV) infection remains a leading cause of hepatic inflammation and damage. The pathogenesis of chronic hepatitis B (CHB) infection is predominantly mediated by persistent intrahepatic immunopathology. With the characterization of unique anatomical and immunological structure, the liver is also deemed an immunological organ, which gives rise to massive cytokines and chemokines under pathogenesis conditions, having significant implications for the progression of HBV infection. The intrahepatic innate immune system is responsible for the formidable source of cytokines and chemokines, with the latter also derived from hepatic parenchymal cells. In addition, systemic cytokines and chemokines are disturbed along with the disease course. Since HBV is a stealth virus, persistent exposure to HBV-related antigens confers to immune exhaustion, whereby regulatory cells are recruited by intrahepatic chemokines and cytokines, including interleukin-10 and transforming growth factor β, are involved in such series of causal events. Although the considerable value of two types of available approved treatment, interferons and nucleos(t)ide analogues, effectively suppress HBV replication, neither of them is sufficient for optimal restoration of the immunological attrition state to win the battle of the functional or virological cure of CHB infection. Notably, cytokines and chemokines play a crucial role in regulating the immune response. They exert effects by directly acting on HBV or indirectly manipulating target immune cells. As such, specific cytokines and chemokines, with a potential possibility to serve as novel immunological interventions, combined with those that target the virus itself, seem to be promising prospects in curative CHB infection. Here, we systematically review the recent literature that elucidates cytokine and chemokine-mediated pathogenesis and immune exhaustion of HBV infection and their dynamics triggered by current mainstream anti-HBV therapy. The predictive value of disease progression or control and the immunotherapies target of specific major cytokines and chemokines in CHB infection will also be delineated.

Circulating Th1 and Th2 Cytokines in Patients with Hepatitis C Virus Infection.

Circulating Th 1 and Th 2 cytokines in patients with hepatitis C virus infection

Analysis on Clinical Features and Immunity in Chronic Hepatitis B Virus Infected Patients with Low-Level Hbsag

Cytokines and Chemokines in HBV Infection

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control During Antiviral Therapy

Imbalance of Regulatory T Cells and T Helper Type 17 Cells in Patients with Chronic Hepatitis C

[Cytokine levels in serum of patients with chronic hepatitis C and its significance].

Effect of IL‐12 on T‐cell Immune Responses in Patients with Chronic HCV Infection

Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.

Immunologic Characterization of Posthepatitis Cirrhosis Caused by HBV and HCV Infection

Th1/Th2 cytokine balance in patients with severe chronic hepatitis B and its relationship with prognosis

Evaluation of Some Cellular Immunologic Index in Chronic Hepatitis C Patients and Its Significance

Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients

Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B

Proapoptotic IL-18 in Patients with Chronic Hepatitis C Treated with Pegylated Interferon-Alpha

Detection of serum slL-2R, IL-6, IL-8,TNF-α and lymphocytes subsets, mIL-2R in patients with chronic hepatitis B

Effects of the Treg/Th17 Cell Balance and Their Associated Cytokines in Patients with Hepatitis B Infection

Th1/Th2 Type Cytokines Expression in Peripheral Blood Cell of the Patients with Hepatitis B Virus Infection and Its Clinical Significance

The research of CD4+CD25+Treg and partial cytokines from patients with chronic hepatitis B